143 related articles for article (PubMed ID: 35114790)
1. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers.
Lima T; Ferreira R; Freitas M; Henrique R; Vitorino R; Fardilha M
J Proteome Res; 2022 Feb; 21(2):447-458. PubMed ID: 35114790
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways.
Lima T; Henrique R; Vitorino R; Fardilha M
Med Oncol; 2021 Jan; 38(1):9. PubMed ID: 33452612
[TBL] [Abstract][Full Text] [Related]
3. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.
Principe S; Kim Y; Fontana S; Ignatchenko V; Nyalwidhe JO; Lance RS; Troyer DA; Alessandro R; Semmes OJ; Kislinger T; Drake RR; Medin JA
J Proteome Res; 2012 Apr; 11(4):2386-96. PubMed ID: 22339264
[TBL] [Abstract][Full Text] [Related]
4. The discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles.
Chen M; Wang K; Zhang L; Li C; Yang Y
PLoS One; 2011; 6(12):e28552. PubMed ID: 22194848
[TBL] [Abstract][Full Text] [Related]
5. In-depth proteomic analyses of direct expressed prostatic secretions.
Drake RR; Elschenbroich S; Lopez-Perez O; Kim Y; Ignatchenko V; Ignatchenko A; Nyalwidhe JO; Basu G; Wilkins CE; Gjurich B; Lance RS; Semmes OJ; Medin JA; Kislinger T
J Proteome Res; 2010 May; 9(5):2109-16. PubMed ID: 20334419
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
7. A peptide-centric approach to analyse quantitative proteomics data- an application to prostate cancer biomarker discovery.
Lima T; Rodrigues JE; Manadas B; Henrique R; Fardilha M; Vitorino R
J Proteomics; 2023 Feb; 272():104774. PubMed ID: 36427804
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer.
Chen C; Shen H; Zhang LG; Liu J; Cao XG; Yao AL; Kang SS; Gao WX; Han H; Cao FH; Li ZG
Int J Mol Med; 2016 Jun; 37(6):1576-86. PubMed ID: 27121963
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.
Altintas DM; Allioli N; Decaussin M; de Bernard S; Ruffion A; Samarut J; Vlaeminck-Guillem V
PLoS One; 2013; 8(6):e66278. PubMed ID: 23840433
[TBL] [Abstract][Full Text] [Related]
10. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
[TBL] [Abstract][Full Text] [Related]
11. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
[TBL] [Abstract][Full Text] [Related]
12. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers.
Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y
Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.
Frantzi M; Latosinska A; Merseburger AS; Mischak H
Expert Rev Mol Diagn; 2015; 15(12):1539-54. PubMed ID: 26491818
[TBL] [Abstract][Full Text] [Related]
14. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
15. New markers in prostate cancer: Genomics.
Fuessel S; Wirth MP
Arch Esp Urol; 2019 Mar; 72(2):116-125. PubMed ID: 30855012
[TBL] [Abstract][Full Text] [Related]
16. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
[TBL] [Abstract][Full Text] [Related]
18. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.
Mao C; Ding Y; Xu N
Mol Cell Biochem; 2022 Jan; 477(1):213-223. PubMed ID: 34655417
[TBL] [Abstract][Full Text] [Related]
19. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
20. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
